ERYTECH provides financial update for Q2 2013 admERY July 18, 2013 Newsroom ERYTECH announced today its cash position and its revenues for the second quarter of 2013. You Might Also Like ERYTECH to Participate Fireside Chat at Jefferies Virtual Healthcare Conference June 2, 2020 ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer November 25, 2019 ERYTECH announces three data presentations at the 2015 AACR Annual Meeting March 24, 2015
ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer November 25, 2019
